• MEDIUM
  • Research
  • Tier 1
  • Hard News

NIH awards $3.2M multi-institutional grant to study new oral cancer treatment

Source
Becker's Dental + DSO Review
Author
Cameron Cortigiano

Summary and scoring by The Bell Brief (Dr. Jennifer Bell) using the Drill-Down Protocol. Not the original publisher.

Why it matters for dental

NIH funding for an injectable hydrogel that delivers oral-cancer immunotherapy could eventually change treatment protocols for oral malignancies handled by oral surgeons and head-and-neck specialists.

Key points

  1. 01

    National Institute of Dental and Craniofacial Research awarded a $3.24 million grant to test the SABERGel injectable biomaterial.

  2. 02

    Simon Young (UTHealth Houston School of Dentistry), Jeffrey Hartgerink (Rice University), and Andrew Sikora (UT MD Anderson Cancer Center) are the co-principal investigators.

  3. 03

    The five-year project is scheduled to run through June 2031 and will seek to identify promising hydrogel formulations.

  4. 04

    The research aims to generate preclinical evidence that could guide further development toward potential testing in patients.

Who should care

  • Specialist
  • Academia / research

Read the original

Becker's Dental + DSO Review

Full reporting and any paywalled content live on beckersdental.com. We summarize and score; we do not republish.

Open original
4 stories

By email

Get The Bell Brief

Sorted for your role. Daily or weekly. Confirm by email, unsubscribe anytime.

How often